Similarly, danazol can decrease production of inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-alpha, which probably can restrict their ability to induce proliferation of CLL cells in vivo [10, 27]. This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.